Mr Milad Hanna Specialist urologist
- Patient age group
- Adults
- Consultant registered on
- 18/04/1996
- Primary medical qualifications
- MB BCh FRCS
- Foreign languages
- Gender
- Male
- Services
- Hospitals
Contact
- Phone
- 020 3313 5961
Krsytal James
Background
Mr Milad Hanna is a specialist urologist at Imperial College Healthcare NHS Trust. He is a leading expert in the diagnosis, prevention, and management of kidney stones, with a globally recognised specialisation in lithotripsy techniques. His clinical interests extend to shockwave therapy for conditions such as erectile dysfunction, Peyronie’s disease, chronic prostatitis, and chronic pelvic pain syndrome (CPPS).
Mr Hanna graduated from Cairo University, Egypt, before completing advanced surgical and urological training in Scotland and London. He was subsequently appointed at Charing Cross Hospital, where he led the acute kidney stone management service. He is highly regarded for his expertise in non-invasive stone treatment and has lectured internationally, helping to establish best practices for lithotripsy and decision-making processes in urological care. His work has influenced the setup of similar services in leading medical institutions across the UK and worldwide.
In addition to his NHS work, Mr Hanna remains committed to research and innovation in shockwave therapy, contributing to advancements in patient outcomes for urological conditions.
Expertise
Kidney stone prevention and treatment using lithotripsy. Low intensity shockwave therapy for erectile dysfunction, Peyronie’s disease, chronic prostatitis, and chronic pelvic pain syndrome (CPPS).
Research & publications
Mr Milad Hanna’s research focuses on non-invasive urological treatments, particularly lithotripsy for kidney stones and low-energy shockwave therapy for erectile dysfunction, Peyronie’s disease, and chronic pelvic pain syndrome. He has advanced best practices in these areas, emphasizing decision-making and patient outcome optimization. His work has been published in international journals and presented at global conferences, highlighting innovations in shockwave therapy for vascular (specifically erectile dysfunction and diabetic nephropathy CKD) and musculoskeletal conditions.